Inter- and intra-examiner reliability of footprint pattern analysis obtained from diabetics using the Harris mat.
Inter- and intra-examiner reliability of footprint pattern analysis obtained from diabetics using the Harris mat.
复制标题
使用 Harris 垫从糖尿病患者获得的足迹模式分析的检查者间和检查者内部的可靠性。
DOI：
--
复制
发表时间：
2010
影响因子：
3.4
通讯作者：
Vivianni C. Abreu
中科院分区：
文献类型：
--
作者：
L. Cisneros;T. S. Fonseca;Vivianni C. Abreu
介绍
高足底压力是糖尿病患者溃疡形成的一个危险因素。Harris和Beath足迹垫是用于筛查这些受试者中足部溃疡风险的工具之一。文献中没有关于使用印刷图案标准进行足迹分析的可靠性的报告。
目的
本研究的目的是评估跨和检查员内的可靠性分析的足迹模式获得使用哈里斯和比思足迹垫。
方法
使用足迹垫从41名受试者身上采集足迹。这些图像由三名独立的检查员进行分析。为了研究检查者内部的可靠性，一周后由一名检查者重复分析。
结果
对于检查者间和检查者内分析，对双脚研究的大多数点的加权Kappa系数都很好（K（w）> 0.80）。
结论
使用Harris和Beath足迹垫获得的足迹模式分析标准具有良好的可靠性，检查者之间和检查者内部的一致性非常高。该方法对于涉及一个或多个检查员的分析是可靠的。文章在澳大利亚新西兰临床试验注册中心（ANZCTR）注册，编号为ACTRN12609000693224。
INTRODUCTION
High plantar pressure is a proven risk factor for ulceration among individuals with diabetes mellitus. The Harris and Beath footprinting mat is one of the tools used in screening for foot ulceration risk among these subjects. There are no reports in the literature on the reliability of footprint analysis using print pattern criteria.
OBJECTIVE
The aim of this study was to evaluate the inter- and intra-examiner reliability of the analysis of footprint patterns obtained using the Harris and Beath footprinting mat.
METHODS
Footprints were taken from 41 subjects using the footprinting mat. The images were subjected to analysis by three independent examiners. To investigate the intra-examiner reliability, the analysis was repeated by one of the examiners one week later.
RESULTS
The weighted kappa coefficient was excellent (K(w) > 0.80) for the inter- and intra-examiner analyses for most of the points studied on both feet.
CONCLUSIONS
The criteria for analyzing footprint patterns obtained using the Harris and Beath footprinting mat presented good reliability and high to excellent inter- and intra-examiner agreement. This method is reliable for analyses involving one or more examiners. Article registered in the Australian New Zealand Clinical Trials Registry (ANZCTR) under the number ACTRN12609000693224.
影响因子：
4.6
作者：
Costa, Y. M.;Karlsson, P.;Baad-Hansen, L.
通讯作者：
Baad-Hansen, L.